ZIVO Bioscience Stock Forecast, Price & News

ZIVO Bioscience (OTCMKTS:ZIVO) Frequently Asked Questions

Is ZIVO Bioscience a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ZIVO Bioscience in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ZIVO Bioscience stock.
View analyst ratings for ZIVO Bioscience or view top-rated stocks.

How has ZIVO Bioscience's stock been impacted by COVID-19?

ZIVO Bioscience's stock was trading at $0.14 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ZIVO shares have increased by 1,892.9% and is now trading at $2.79.
View which stocks have been most impacted by COVID-19.

How were ZIVO Bioscience's earnings last quarter?

ZIVO Bioscience, Inc. (OTCMKTS:ZIVO) released its quarterly earnings data on Monday, November, 15th. The biotechnology company reported ($0.21) earnings per share (EPS) for the quarter.
View ZIVO Bioscience's earnings history.

What price target have analysts set for ZIVO?

1 Wall Street analysts have issued twelve-month price targets for ZIVO Bioscience's stock. Their forecasts range from $9.00 to $9.00. On average, they expect ZIVO Bioscience's share price to reach $9.00 in the next twelve months. This suggests a possible upside of 222.6% from the stock's current price.
View analysts' price targets for ZIVO Bioscience or view top-rated stocks among Wall Street analysts.

Who are ZIVO Bioscience's key executives?

ZIVO Bioscience's management team includes the following people:

• Andrew A. Dahl, President, Chief Executive Officer & Director
• Casey Fowler, Vice President-Operations & Product Development
• Keith R. Marchiando, Chief Financial Officer, Secretary & Treasurer
• Amy Elizabeth Steffek, Director-Research & Development
• William P. Pfund, Vice President-Research & Development

Who are some of ZIVO Bioscience's key competitors?

Some companies that are related to ZIVO Bioscience include Innovator Laddered Fund of S&P 500 Power Buffer ETFs (BUFF), Laird Superfood (LSF), MeaTech 3D (MITC), TDH (PETZ), Stryve Foods (SNAX), Sow Good (SOWG) and New Earth Life Sciences (EFLI).
View all of ZIVO's competitors.

What other stocks do shareholders of ZIVO Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ZIVO Bioscience investors own include Nabriva Therapeutics (NBRV), Collegium Pharmaceutical (COLL), Geron (GERN), Johnson & Johnson (JNJ), Unrivaled Brands (TRTC), Abeona Therapeutics (ABEO), ACADIA Pharmaceuticals (ACAD), Alibaba Group (BABA), (CGC) and Chesapeake Energy (CHKAQ).

What is ZIVO Bioscience's stock symbol?

ZIVO Bioscience trades on the OTCMKTS under the ticker symbol "ZIVO."

How do I buy shares of ZIVO Bioscience?

Shares of ZIVO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ZIVO Bioscience's stock price today?

One share of ZIVO stock can currently be purchased for approximately $2.79.

How much money does ZIVO Bioscience make?

ZIVO Bioscience has a market capitalization of $26.28 million and generates $20 thousand in revenue each year. The biotechnology company earns $-9.11 million in net income (profit) each year or ($1.29) on an earnings per share basis.

How many employees does ZIVO Bioscience have?

ZIVO Bioscience employs 8 workers across the globe.

What is ZIVO Bioscience's official website?

The official website for ZIVO Bioscience is www.zivobioscience.com.

Where are ZIVO Bioscience's headquarters?

ZIVO Bioscience is headquartered at 2804 ORCHARD LAKE ROAD SUITE 202, KEEGO HARBOR MI, 48320.

How can I contact ZIVO Bioscience?

ZIVO Bioscience's mailing address is 2804 ORCHARD LAKE ROAD SUITE 202, KEEGO HARBOR MI, 48320. The biotechnology company can be reached via phone at (248) 452-9866 or via email at [email protected].